Frequency and Spectrum of Actionable Secondary Findings in the Maltese Population
Molecular Genetics & Genomic Medicine · 2025-09 · 13 (9)
DOI: 10.1002/mgg3.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 19.09.2025. Verfasst von Laura Grech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biomedical Sciences, Faculty of Health Sciences, University of Malta, Msida, Malta. Hauptthemen laut MEDLINE: Incidental Findings. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università ta' Malta.
Abstract (Originalsprache)
Background
The identification of actionable secondary findings (SFs) through clinical exome sequencing has become increasingly relevant with the integration of genomics into routine healthcare. The frequency and spectrum of these findings vary across populations.
Methods
We analyzed exome sequencing data from 350 unrelated Maltese individuals, comprising 320 pseudonymised controls and 30 participants from the pilot sequencing phase of the national biobank DwarnaBio, to assess the prevalence of pathogenic or likely pathogenic (P/LP) variants in the ACMG SF v3.2 gene list. All samples underwent uniform sequencing, rigorous quality control, and variant interpretation according to ACMG/AMP guidelines.
Results
Actionable P/LP variants were identified in 12 individuals (3.4%) across autosomal dominant genes, predominantly associated with inherited cardiac conditions and cancer predisposition syndromes. These findings highlight the importance of including underrepresented populations in genomic research and emphasize the need to establish provisions for the return of clinically actionable results to biobank participants, supported by access to genetic counseling.
Conclusion
Our results advocate for the integration of population‐specific genomic data into national precision medicine frameworks, particularly for small or isolated populations where tailored approaches to variant curation and clinical translation are required. This study provides the first baseline estimate of actionable SFs in the Maltese population and offers insights for advancing precision medicine frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Applied Biomedical Sciences, Faculty of Health Sciences, University of Malta, Msida, Malta.
- Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
- Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
ORCID-Profile: Laura Grech, Dillon Mintoff, Nikolai Paul Pace
Förderung
- Università ta' Malta
Zitieren
APA
Grech, L., Grech, C. A., Spiteri, J., Mintoff, D., & Pace, N. P. (2025). Frequency and Spectrum of Actionable Secondary Findings in the Maltese Population. Molecular Genetics & Genomic Medicine, 13(9). https://doi.org/10.1002/mgg3.70143
Vancouver
Grech L, Grech CA, Spiteri J, Mintoff D, Pace NP. Frequency and Spectrum of Actionable Secondary Findings in the Maltese Population. Molecular Genetics & Genomic Medicine. 2025;13(9). doi:10.1002/mgg3.70143
BibTeX
@article{Grech2025,
author = {Grech, Laura and Grech, Celine Ann and Spiteri, Jasmine and Mintoff, Dillon and Pace, Nikolai Paul},
title = {Frequency and Spectrum of Actionable Secondary Findings in the Maltese Population},
journal = {Molecular Genetics & Genomic Medicine},
year = {2025},
volume = {13},
number = {9},
doi = {10.1002/mgg3.70143}
}
EUVIMED